Cargando…
Plant-Produced Anti-Zika Virus Monoclonal Antibody Glycovariant Exhibits Abrogated Antibody-Dependent Enhancement of Infection
Monoclonal antibodies (mAb) against the envelope (E) protein of Zika virus (ZIKV) have shown great potential as therapeutics against the Zika epidemics. However, their use as a therapy may predispose treated individuals to severe infection by the related dengue virus (DENV) via antibody-dependent en...
Autores principales: | Yang, Ming, Sun, Haiyan, Lai, Huafang, Neupane, Biswas, Bai, Fengwei, Steinkellner, Herta, Chen, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144123/ https://www.ncbi.nlm.nih.gov/pubmed/37112665 http://dx.doi.org/10.3390/vaccines11040755 |
Ejemplares similares
-
A Dual-Approach Strategy to Optimize the Safety and Efficacy of Anti-Zika Virus Monoclonal Antibody Therapeutics
por: Sun, Haiyan, et al.
Publicado: (2023) -
In vitro and in vivo efficacy of anti‐chikungunya virus monoclonal antibodies produced in wild‐type and glycoengineered Nicotiana benthamiana plants
por: Hurtado, Jonathan, et al.
Publicado: (2019) -
A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus
por: Esqueda, Adrian, et al.
Publicado: (2023) -
The potency and synergy of plant‐made monoclonal antibodies against the BA.5 variant of SARS‐CoV‐2
por: Sun, Haiyan, et al.
Publicado: (2023) -
A novel plant‐made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS‐CoV‐2 Omicron variant
por: Jugler, Collin, et al.
Publicado: (2022)